Suppr超能文献

砷和铅诱导自由基生成及其螯合后的可逆性。

Arsenic and lead induced free radical generation and their reversibility following chelation.

作者信息

Flora S J S, Flora G, Saxena G, Mishra M

机构信息

Division of Pharmacology and Toxicology, Defence Research and Development Establishment, Gwalior, India.

出版信息

Cell Mol Biol (Noisy-le-grand). 2007 Apr 15;53(1):26-47.

Abstract

Health hazards caused by heavy metals have become a great concern to the population. Lead and arsenic are one of the most important current global environmental toxicants. Their toxic manifestations are being considered caused primarily due to the imbalance between pro-oxidant and antioxidant homeostasis and also due to a high affinity of these metals for thiol groups on functional proteins. They also interfere with a number of other body functions and are known to affect central nervous system (CNS), hematopoietic system, liver and kidneys and produce serious disorders. They produce both acute and chronic poisoning, of which chronic poisoning is more dangerous as its very difficult to revert back to normal condition after chronic exposure to these insidious metals present in our life. Despite many years of research, we are still far from an effective treatment of chronic plumbism and arsenicosis. Current approved treatment lies in the administration of chelating agents that forms an insoluble complex with the metal and removes it. They have been used clinically as antidotes for treating acute and chronic poisoning. The most widely used chelating agents are calcium disodium ethylenediamine tetra acetic acid (CaNa2EDTA), D-penicillamine and British anti-lewisite (BAL). Meso 2,3 dimercaptosuccinic acid (DMSA), an analogue of BAL, has been tried successfully in animals as well as in humans. But it is unable to remove the metal from intracellular sites. Effective chelation therapy for intoxication by heavy metals depends on whether the chelating agents are able to reach the intracellular site where the heavy metal is firmly bound. One of the important approaches has been the use of combination therapy. This includes use of structurally different chelators or a combination of an adjuvant/ antioxidant/ herbal extracts and a chelator to provide better clinical/ biochemical recovery. A number of other strategies have been suggested to minimize the numerous problems. This article presents the recent development made in this area with possible directions for future research.

摘要

重金属造成的健康危害已成为公众高度关注的问题。铅和砷是当前全球最重要的环境毒物之一。人们认为它们的毒性表现主要是由于促氧化剂和抗氧化剂稳态失衡,以及这些金属对功能蛋白上硫醇基团的高亲和力。它们还会干扰许多其他身体功能,已知会影响中枢神经系统(CNS)、造血系统、肝脏和肾脏,并引发严重疾病。它们会导致急性和慢性中毒,其中慢性中毒更危险,因为长期接触生活中这些隐匿的金属后很难恢复到正常状态。尽管经过多年研究,我们仍远未找到有效治疗慢性铅中毒和砷中毒的方法。目前批准的治疗方法是使用螯合剂,螯合剂与金属形成不溶性复合物并将其清除。它们已在临床上用作治疗急性和慢性中毒的解毒剂。使用最广泛的螯合剂是乙二胺四乙酸二钠钙(CaNa2EDTA)、D-青霉胺和二巯丙醇(BAL)。二巯基丁二酸(DMSA)是BAL的类似物,已在动物和人体中成功试验。但它无法从细胞内位点去除金属。针对重金属中毒的有效螯合疗法取决于螯合剂是否能够到达重金属牢固结合的细胞内位点。重要的方法之一是联合治疗。这包括使用结构不同的螯合剂,或辅助剂/抗氧化剂/草药提取物与螯合剂的组合,以实现更好的临床/生化恢复。人们还提出了许多其他策略来尽量减少众多问题。本文介绍了该领域的最新进展以及未来可能的研究方向。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验